Gamma ‐synuclein is a novel prognostic marker that promotes tumor cell migration in biliary tract carcinoma

In conclusion, SNCG may promote tumor cell activity and is potentially a novel prognostic marker in BTC.

Source: Cancer Medicine - July 10, 2021 Category: Cancer & Oncology Authors: Yusuke Takemura, Hidenori Ojima, Go Oshima, Masahiro Shinoda, Yasushi Hasegawa, Minoru Kitago, Hiroshi Yagi, Yuta Abe, Shutaro Hori, Yoko Fujii ‐Nishimura, Naoto Kubota, Yuki Masuda, Taizo Hibi, Michiie Sakamoto, Yuko Kitagawa Tags: ORIGINAL RESEARCH Source Type: research